Minomic is pleased to announce its participation in a deal-making session at the Asia Summit on Global Health, taking place on 11–12 May 2026 at the Hong Kong Convention and Exhibition Centre (HKCEC).
This premier global forum brings together leading healthcare innovators, investors, and strategic partners to accelerate high-impact collaborations across the life sciences sector.
Our CEO, Sushmita Utpala, will be on site representing Minomic and showcasing the progress of MiCheck® Prostate, our next-generation prostate cancer diagnostic platform designed to advance early detection and improve patient outcomes.
We are now opening our deal-making calendar and actively scheduling meetings with:
This premier global forum brings together leading healthcare innovators, investors, and strategic partners to accelerate high-impact collaborations across the life sciences sector.
Our CEO, Sushmita Utpala, will be on site representing Minomic and showcasing the progress of MiCheck® Prostate, our next-generation prostate cancer diagnostic platform designed to advance early detection and improve patient outcomes.
We are now opening our deal-making calendar and actively scheduling meetings with:
- Strategic investors
- Diagnostics partners
- Healthcare providers and distributors
📅 11–12 May 2026 | 📍 Hong Kong (HKCEC)
👉 Book a meeting with Sushmita Utpala to explore partnership opportunities and learn how Minomic is helping redefine precision diagnostics in prostate cancer.
We encourage you to connect ahead of the event to secure your preferred time slot.
